The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The
https://
ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
Zhongguo Dang Dai Er Ke Za Zhi.
2023 Mar 15; 25(3): 238–243.
Language:
Chinese
|
English
儿童不完全性川崎病的诊治
Diagnosis and treatment of incomplete Kawasaki disease in children
,
1
,
1
,
2
,
3
,
4
,
5
and
6
焦 富勇
陕西省川崎病诊疗中心/陕西省人民医院儿童病院, ，陕西
710068
穆 志龙
陕西省川崎病诊疗中心/陕西省人民医院儿童病院, ，陕西
710068
杜 忠东
国家儿童医学中心/首都医科大学 附属北京儿童医院,
100045
杨 晓东
上海交通大学医学院附属儿童医院,
200040
沈 捷
国家儿童医学 中心/上海交通大学医学院附属儿童医学中心,
200120
向 伟
海南省妇女儿童医学中心/国家卫健委热带病 防治重点实验室, ，海南
570206
王 虹
中国医科大学附属盛京医院小儿心脏病科, ，辽宁
陕西省川崎病诊疗中心/陕西省人民医院儿童病院, ，陕西
710068
国家儿童医学中心/首都医科大学 附属北京儿童医院,
100045
上海交通大学医学院附属儿童医院,
200040
国家儿童医学 中心/上海交通大学医学院附属儿童医学中心,
200120
海南省妇女儿童医学中心/国家卫健委热带病 防治重点实验室, ，海南
570206
中国医科大学附属盛京医院小儿心脏病科, ，辽宁
110004
Corresponding author.
Ae R, Makino N, Kosami K, et al..
Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018
[J].
J Pediatr
, 2020,
225
: 23-29.e2. DOI: 10.1016/j.jpeds.2020.05.034. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
2.
McCrindle BW, Rowley AH, Newburger JW, et al..
Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association
[J].
Circulation
, 2017,
135
(
17
): e927-e999. DOI: 10.1161/CIR.0000000000000484. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
3.
Kobayashi T, Ayusawa M, Suzuki H, et al..
Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)
[J].
Pediatr Int
, 2020,
62
(
10
): 1135-1138. DOI: 10.1111/ped.14326. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
4.
穆志龙, 焦富勇, 谢凯生.
《川崎病心血管后遗症的诊断和管理指南(JCS/JSCS2020)》解读
[J].
中国当代儿科杂志
, 2021,
23
(
3
): 213-220. DOI: 10.7499/j.issn.1008-8830.2010134. [
CrossRef
]
[
Google Scholar
]
5.
Manlhiot C, Christie E, McCrindle BW, et al..
Complete and incomplete Kawasaki disease: two sides of the same coin
[J].
Eur J Pediatr
, 2012,
171
(
4
): 657-662. DOI: 10.1007/s00431-011-1631-2. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
6.
Morishita KA, Goldman RD.
Current approach to the evaluation and management of incomplete Kawasaki disease in the emergency department
[J].
Pediatr Emerg Care
, 2020,
36
(
11
): 537-541. DOI: 10.1097/PEC.0000000000002259. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
7.
Wu J, Yu M, Huang L, et al..
Association of MnSOD gene polymorphism with susceptibility to Kawasaki disease in Chinese children
[J].
Cardiol Young
, 2021,
31
(
2
): 179-185. DOI: 10.1017/S104795112000356X. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
8.
刘庚英, 杜忠东.
不完全川崎病的诊治
[J].
中国小儿急救医学
, 2020,
27
(
9
): 666-670. DOI: 10.3760/cma.j.issn.1673-4912.2020.09.007. [
CrossRef
]
[
Google Scholar
]
9.
张新艳, 杨婷婷, 何婷, 等.
2012至2016年单中心川崎病流行病学及临床特征研究
[J].
中国循证儿科杂志
, 2018,
13
(
6
): 427-433. DOI: 10.3969/j.issn.1673-5501.2018.06.006. [
CrossRef
]
[
Google Scholar
]
10.
Sonobe T, Kiyosawa N, Tsuchiya K, et al..
Prevalence of coronary artery abnormality in incomplete Kawasaki disease
[J].
Pediatr Int
, 2007,
49
(
4
): 421-426. DOI: 10.1111/j.1442-200X.2007.02396.x. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
11.
Nomura Y, Yashiro M, Masuda K, et al..
Treatment change and coronary artery abnormality in incomplete Kawasaki disease
[J].
Pediatr Int
, 2020,
62
(
7
): 779-784. DOI: 10.1111/ped.14242. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
12.
Shi L, Li J, Qie D, et al..
Clinical manifestations of Kawasaki disease in different age groups: retrospective data from Southwest China
[J].
Clin Rheumatol
, 2020,
39
(
10
): 3027-3032. DOI: 10.1007/s10067-020-05069-5. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
13.
Liu HH, Qiu Z, Fan GZ, et al..
Assessment of coronary artery abnormalities and variability of Z-score calculation in the acute episode of Kawasaki disease: a retrospective study from China
[J].
Eur J Clin Invest
, 2021,
51
(
3
): e13409. DOI: 10.1111/eci.13409. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
14.
Blaney MM, Williams RV, Areinamo IA, et al..
The impact of the American Heart Association guidelines on patients treated for incomplete Kawasaki disease
[J].
Cardiol Young
, 2022,
32
(
7
): 1066-1070. DOI: 10.1017/S1047951121003632. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
15.
Sudo D, Makino N, Nakamura Y.
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan
[J].
Arch Dis Child
, 2020,
105
(
9
): 848-852. DOI: 10.1136/archdischild-2019-317238. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
16.
Alramadhan MM, Kamdar AA, Lafferty-Prather M, et al..
Incomplete Kawasaki disease associated with human herpes virus-6 variant B infection and aseptic meningitis
[J].
Glob Pediatr Health
, 2020,
7
: 2333794X20939759. DOI: 10.1177/2333794X20939759.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
17.
Fukazawa R, Kobayashi J, Ayusawa MU, et al..
JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease
[J].
Circ J
, 2020,
84
(
8
): 1348-1407. DOI: 10.1253/circj.CJ-19-1094. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
18.
Shi H, Qiu H, Jin Z, et al..
Coronary artery lesion risk and mediating mechanism in children with complete and incomplete Kawasaki disease
[J].
J Investig Med
, 2019,
67
(
6
): 950-956. DOI: 10.1136/jim-2018-000898. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
19.
Li T, Feng J, Li N, et al..
Correct identification of incomplete Kawasaki disease
[J].
J Int Med Res
, 2021,
49
(
3
): 3000605211001712. DOI: 10.1177/03000605211001712.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
20.
Yoon YM, Yun HW, Kim SH.
Clinical characteristics of Kawasaki disease in infants younger than six months: a single-center study
[J].
Korean Circ J
, 2016,
46
(
4
): 550-555. DOI: 10.4070/kcj.2016.46.4.550.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
21.
李晓冰, 何德根, 彭通, 等.
完全性川崎病与不完全性川崎病患儿临床特点比较
[J].
中国妇幼健康研究
, 2018,
29
(
5
): 618-621. DOI: 10.3969/j.issn.1673-5293.2018.05.020. [
CrossRef
]
[
Google Scholar
]
22.
黄国英.
川崎病诊断和治疗面临的挑战
[J].
中华儿科杂志
, 2022,
60
(
1
): 3-5. DOI: 10.3760/cma.j.cn112140-20211104-00927. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
23.
Denby KJ, Clark DE, Markham LW.
Management of Kawasaki disease in adults
[J].
Heart
, 2017,
103
(
22
): 1760-1769. DOI: 10.1136/heartjnl-2017-311774. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
24.
An HS, Kim GB, Song MK, et al..
The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study
[J].
Pediatr Rheumatol Online J
, 2021,
19
(
1
): 78. DOI: 10.1186/s12969-021-00566-6.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
25.
中华医学会儿科学分会心血管学组, 中华医学会儿科学分会风湿学组, 中华医学会儿科学分会免疫学组, 等.
川崎病诊断和急性期治疗专家共识
[J].
中华儿科杂志
, 2022,
60
(
1
): 6-13. DOI: 10.3760/cma.j.cn112140-20211018-00879. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
26.
Rodriguez-Gonzalez M, Perez-Reviriego AA, Castellano-Martinez A, et al..
N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease
[J].
Biomark Med
, 2019,
13
(
4
): 307-323. DOI: 10.2217/bmm-2018-0324. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
27.
余诚, 蒋罗.
不完全川崎病的诊治研究
[J].
临床医药文献电子杂志
, 2016,
3
(
20
): 3999-4000. DOI: 10.16281/j.cnki.jocml.2016.20.047. [
CrossRef
]
[
Google Scholar
]
28.
Shimizu A, Ebara Y, Nomura S, et al..
Chronological changes in strawberry tongue in toxic shock syndrome toxin-1-mediated exanthematous disease
[J].
J Gen Fam Med
, 2020,
21
(
6
): 280-281. DOI: 10.1002/jgf2.376.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
29.
Kanemasa H, Nanishi E, Takada H, et al..
Overlapping features in Kawasaki disease-related arthritis and systemic-onset juvenile idiopathic arthritis: a nationwide study in Japan
[J].
Front Pediatr
, 2021,
9
: 597458. DOI: 10.3389/fped.2021.597458.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
30.
Otar Yener G, Paç Kısaarslan A, Ulu K, et al..
Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis: a comparative study
[J].
Rheumatol Int
, 2022,
42
(
5
): 879-889. DOI: 10.1007/s00296-021-04980-7.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
31.
Rosenfeld N, Tasher D, Ovadia A, et al..
Kawasaki disease with a concomitant primary Epstein-Barr virus infection
[J].
Pediatr Rheumatol Online J
, 2020,
18
(
1
): 65. DOI: 10.1186/s12969-020-00459-0.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
32.
Sun G, Yao F, Yang Z.
A pediatric case report of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with pericardial effusion and multiple coronary artery aneurysms
[J].
J Pediatr Hematol Oncol
, 2021,
43
(
2
): e219-e222. DOI: 10.1097/MPH.0000000000001642. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
33.
Jaggi P, Kajon AE, Mejias A, et al..
Human adenovirus infection in Kawasaki disease: a confounding bystander?
[J].
Clin Infect Dis
, 2013,
56
(
1
): 58-64. DOI: 10.1093/cid/cis807.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
34.
Tang Y, Li X, Cao L, et al..
Characteristics and indications of Kawasaki disease among infants under 6 months
[J].
Front Pediatr
, 2020,
8
: 470. DOI: 10.3389/fped.2020.00470.
[
PMC free article
]
[
PubMed
] [
CrossRef
]
[
Google Scholar
]
36.
陕西省川崎病诊疗中心/陕西省人民医院儿童病院, 上海交通大学附属儿童医院, 首都医科大学附属北京儿童医院, 等.
阿司匹林在川崎病治疗中的儿科专家共识
[J].
中国当代儿科杂志
, 2022,
24
(
6
): 597-603. DOI: 10.7499/j.issn.1008-8830.2203190. [
CrossRef
]
[
Google Scholar
]
37.
Nomura Y, Yashiro M, Masuda K, et al..
Treatment change and coronary artery abnormality in incomplete Kawasaki disease
[J].
Pediatr Int
, 2020,
62
(
7
): 779-784. DOI: 10.1111/ped.14242. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
38.
中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会 .
川崎病冠状动脉病变的临床处理建议(2020年修订版)
[J].
中华儿科杂志
, 2020,
58
(
9
): 718-724. DOI: 10.3760/cma.j.cn112140-20200422-00421. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
39.
Yang TJ, Lin MT, Lu CY, et al..
The prevention of coronary arterial abnormalities in Kawasaki disease: a meta-analysis of the corticosteroid effectiveness
[J].
J Microbiol Immunol Infect
, 2018,
51
(
3
): 321-331. DOI: 10.1016/j.jmii.2017.08.012. [
PubMed
] [
CrossRef
]
[
Google Scholar
]
Articles from
Chinese Journal of Contemporary Pediatrics
are provided here courtesy of
Xiangya Hospital, Central South University
